Pages that link to "Q28255508"

The following pages link to IRAK-4 inhibitors for inflammation (Q28255508):

Displaying 41 items.

• Toll-like receptors in systemic lupus erythematosus: potential targets for therapeutic intervention (Q26865485) (← links)
• IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance (Q26866390) (← links)
• Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4 (Q28078574) (← links)
• Augmentation of therapeutic responses in melanoma by inhibition of IRAK-1,-4 (Q28276508) (← links)
• Dual Inhibition of Rip2 and IRAK1/4 Regulates IL-1β and IL-6 in Sarcoidosis Alveolar Macrophages and Peripheral Blood Mononuclear Cells (Q28385953) (← links)
• Structural dynamic analysis of apo and ATP-bound IRAK4 kinase (Q30584224) (← links)
• Identification of critical functional residues of receptor-like kinase ERECTA. (Q33719733) (← links)
• Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies (Q33889168) (← links)
• A coding IRAK2 protein variant compromises Toll-like receptor (TLR) signaling and is associated with colorectal cancer survival (Q34044755) (← links)
• Kinase drug discovery--what's next in the field? (Q34527876) (← links)
• Invasive pneumococcal diseases in children and adolescents--a single centre experience (Q35119564) (← links)
• The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease (Q35137421) (← links)
• Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapies (Q35183900) (← links)
• Discovery of 5-Amino-N-(1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide Inhibitors of IRAK4. (Q35745161) (← links)
• Targeting IRAK1 in T-cell acute lymphoblastic leukemia (Q36326296) (← links)
• Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy (Q36398777) (← links)
• Suppression of TLR signaling by targeting TIR domain-containing proteins (Q36676056) (← links)
• Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome (Q37011627) (← links)
• Targeting interleukin-1 receptor-associated kinase 1 for human hepatocellular carcinoma (Q37251454) (← links)
• Protection of ischemic post conditioning against transient focal ischemia-induced brain damage is associated with inhibition of neuroinflammation via modulation of TLR2 and TLR4 pathways (Q37538123) (← links)
• Can interaction of materials with the dentin-pulp complex contribute to dentin regeneration? (Q37692275) (← links)
• The biology of interleukin-1: emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics (Q37899787) (← links)
• Endotoxin Tolerance Attenuates Liver Ischemia/Reperfusion Injury by Down-Regulation of Interleukin-1 Receptor-Associated Kinase 4 in Kupffer Cells (Q38331956) (← links)
• Role of Microglial Activation in the Pathophysiology of Bacterial Meningitis (Q38368299) (← links)
• Lack of IL-1 Receptor-Associated Kinase-4 Leads to Defective Th1 Cell Responses and Renders Mice Susceptible to Mycobacterial Infection (Q38756763) (← links)
• The critical role of lipopolysaccharide in the upregulation of aquaporin 4 in glial cells treated with Shiga toxin (Q38834209) (← links)
• Inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4): a patent review (2012-2015). (Q38866932) (← links)
• Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease. (Q38882099) (← links)
• Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases (Q39413866) (← links)
• A mechanistic pharmacodynamic model of IRAK-4 drug inhibition in the Toll-like receptor pathway (Q45192851) (← links)
• Immune Complex-Mediated Cell Activation from Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients Elaborate Different Requirements for IRAK1/4 Kinase Activity across Human Cell Types (Q45212066) (← links)
• Activation of inflammatory immune gene cascades by lipopolysaccharide (LPS) in the porcine colonic tissue ex-vivo model (Q51645996) (← links)
• Blocking innate immunity to slow the progression of chronic kidney disease. (Q54332028) (← links)
• Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats. (Q54335772) (← links)
• Recurrent Staphylococcus aureus abscess and fatal pneumococcal septicemia due to IRAK-4 deficiency. (Q55033232) (← links)
• Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor (Q57789918) (← links)
• Design of a Novel and Selective IRAK4 Inhibitor Using Topological Water Network Analysis and Molecular Modeling Approaches (Q60928903) (← links)
• Inhibition of Interleukin-1 Receptor-Associated Kinases 1/4, Increases Gene Expression and Serum Level of Adiponectin in Mouse Model of Insulin Resistance (Q90358686) (← links)
• TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner (Q92239398) (← links)
• Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4-MyD88 Complex (Q92458842) (← links)
• The E3 ubiquitin ligase SPOP controls resolution of systemic inflammation by triggering MYD88 degradation (Q92579042) (← links)